Essential role of calcium in vascular endothelial growth factor A‐induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole
- 19 September 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 16 (13), 1-29
- https://doi.org/10.1096/fj.01-0938fje
Abstract
Vascular endothelial growth factor‐α (VEGF‐A) plays a major role in tumor angiogenesis and raises the concentration of intracellular free calcium ([Ca2+]i). Carboxyamidotriazole (CAI), an inhibitor of calcium influx and of angiogenesis, is under investigation as a tumoristatic agent. We studied the effect of CAI and the role of [Ca2+]i in VEGF‐α signaling in human endothelial cells. VEGF‐α induced a biphasic [Ca2+]i signal. VEGF‐α increased the level of intracellular inositol 1,4,5‐trisphosphate (IP3), which suggests that VEGF‐A releases Ca2+ from IP3‐sensitive stores and induces store‐operated calcium influx. Reduction of either extracellular or intracellular free Ca2+ inhibited VEGF‐A‐induced proliferation. CAI inhibited IP3 formation, both phases of the calcium signal, nitric oxide (NO) release, and proliferation induced by VEGF‐A. CAI prevented neither activation of VEGF receptor‐2 (VEGFR‐2) (KDR/Flk‐1), phospholipase C‐γ, or mitogen‐activated protein kinase (MAP kinase) nor translocation of nuclear factor of activated T cells (NFAT). We conclude that calcium signaling is necessary for VEGF‐A‐induced proliferation. MAP kinase activation occurs independently of [Ca2+]i but is not sufficient to induce proliferation in the absence of calcium signaling. Inhibition of the VEGF‐Ainduced [Ca2+]i signal and proliferation by CAI can be explained by inhibition of IP3 formation and may contribute to the antiangiogenic action of CAI. Calcium‐dependent NO formation may represent a link between calcium signaling and proliferation.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB497/C1, SFB451/B1, WA734/5-1)
- Merck Sharp and Dohme United Kingdom
This publication has 50 references indexed in Scilit:
- A Novel Function of VEGF Receptor-2 (KDR): Rapid Release of Nitric Oxide in Response to VEGF-A Stimulation in Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- VEGF-A Induces Expression of eNOS and iNOS in Endothelial Cells via VEGF Receptor-2 (KDR)Biochemical and Biophysical Research Communications, 1998
- Clotrimazole, an Imidazole Antimycotic, Is a Potent Inhibitor of AngiogenesisJapanese Journal of Cancer Research, 1998
- The Role of Calcium in the Cell Cycle: Facts and HypothesesBiochemical and Biophysical Research Communications, 1998
- Mechanisms of angiogenesisNature, 1997
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Anti‐proliferative activity of L‐651,582 correlates with calcium‐mediated regulation of nucleotide metabolism at phosphoribosyl pyrophosphate synthetaseJournal of Cellular Physiology, 1990
- L651582: A Novel Antiproliferative and Antimetastasis AgentJNCI Journal of the National Cancer Institute, 1990
- Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activityJournal of Neurosurgery, 1989
- Rat Brain Capillary Endothelial Cells Express Functional PDGF B-Type ReceptorsGrowth Factors, 1989